These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32591930)

  • 1. Design and in vitro analysis of SIRT2 inhibitor targeting Parkinson's disease.
    Singh AP; Nigam L; Yadav Y; Shekhar S; Subbarao N; Dey S
    Mol Divers; 2021 Nov; 25(4):2261-2270. PubMed ID: 32591930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.
    Kiviranta PH; Suuronen T; Wallén EA; Leppänen J; Tervonen J; Kyrylenko S; Salminen A; Poso A; Jarho EM
    J Med Chem; 2009 Apr; 52(7):2153-6. PubMed ID: 19296597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide.
    Smith BC; Denu JM
    Biochemistry; 2007 Dec; 46(50):14478-86. PubMed ID: 18027980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson's disease model.
    Di Fruscia P; Zacharioudakis E; Liu C; Moniot S; Laohasinnarong S; Khongkow M; Harrison IF; Koltsida K; Reynolds CR; Schmidtkunz K; Jung M; Chapman KL; Steegborn C; Dexter DT; Sternberg MJ; Lam EW; Fuchter MJ
    ChemMedChem; 2015 Jan; 10(1):69-82. PubMed ID: 25395356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.
    Peck B; Chen CY; Ho KK; Di Fruscia P; Myatt SS; Coombes RC; Fuchter MJ; Hsiao CD; Lam EW
    Mol Cancer Ther; 2010 Apr; 9(4):844-55. PubMed ID: 20371709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.
    Suzuki T; Khan MN; Sawada H; Imai E; Itoh Y; Yamatsuta K; Tokuda N; Takeuchi J; Seko T; Nakagawa H; Miyata N
    J Med Chem; 2012 Jun; 55(12):5760-73. PubMed ID: 22642300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding Potent Sirt Inhibitor in Coffee: Isolation, Confirmation and Synthesis of Javamide-II (N-Caffeoyltryptophan) as Sirt1/2 Inhibitor.
    Park JB
    PLoS One; 2016; 11(3):e0150392. PubMed ID: 26986569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N(epsilon)-Modified lysine containing inhibitors for SIRT1 and SIRT2.
    Huhtiniemi T; Suuronen T; Lahtela-Kakkonen M; Bruijn T; Jääskeläinen S; Poso A; Salminen A; Leppänen J; Jarho E
    Bioorg Med Chem; 2010 Aug; 18(15):5616-25. PubMed ID: 20630764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.
    Outeiro TF; Kontopoulos E; Altmann SM; Kufareva I; Strathearn KE; Amore AM; Volk CB; Maxwell MM; Rochet JC; McLean PJ; Young AB; Abagyan R; Feany MB; Hyman BT; Kazantsev AG
    Science; 2007 Jul; 317(5837):516-9. PubMed ID: 17588900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic peptide-based potent and selective SIRT1/2 dual inhibitors harboring N
    Chen D; Zheng W
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5234-5239. PubMed ID: 27707605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Role of Sirtuin 2 in Parkinson's Disease.
    Liu Y; Zhang Y; Zhu K; Chi S; Wang C; Xie A
    Front Aging Neurosci; 2019; 11():372. PubMed ID: 31998119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.
    Hoffmann G; Breitenbücher F; Schuler M; Ehrenhofer-Murray AE
    J Biol Chem; 2014 Feb; 289(8):5208-16. PubMed ID: 24379401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Selective SIRT2 Inhibitors as Therapeutic Agents in B-Cell Lymphoma and Other Malignancies.
    Chowdhury S; Sripathy S; Webster A; Park A; Lao U; Hsu JH; Loe T; Bedalov A; Simon JA
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31973227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rs2015 Polymorphism in miRNA Target Site of Sirtuin2 Gene Is Associated with the Risk of Parkinson's Disease in Chinese Han Population.
    Chen X; Mai H; Chen X; Cai Y; Cheng Q; Chen X; Li X; Fan W; Tang P; Ou M; Yang J; Chen Y; Cui L
    Biomed Res Int; 2019; 2019():1498034. PubMed ID: 31214610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SIRT2 by Targeting GSK3β-Mediated Phosphorylation Alleviates SIRT2 Toxicity in SH-SY5Y Cells.
    Liu S; Zhou Z; Zhang L; Meng S; Li S; Wang X
    Front Cell Neurosci; 2019; 13():148. PubMed ID: 31105527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituting N(epsilon)-thioacetyl-lysine for N(epsilon)-acetyl-lysine in peptide substrates as a general approach to inhibiting human NAD(+)-dependent protein deacetylases.
    Fatkins DG; Zheng W
    Int J Mol Sci; 2008 Jan; 9(1):1-11. PubMed ID: 19325715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-212-5p Prevents Dopaminergic Neuron Death by Inhibiting SIRT2 in MPTP-Induced Mouse Model of Parkinson's Disease.
    Sun S; Han X; Li X; Song Q; Lu M; Jia M; Ding J; Hu G
    Front Mol Neurosci; 2018; 11():381. PubMed ID: 30364275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.
    North BJ; Marshall BL; Borra MT; Denu JM; Verdin E
    Mol Cell; 2003 Feb; 11(2):437-44. PubMed ID: 12620231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bicyclic pentapeptide-based highly potent and selective pan-SIRT1/2/3 inhibitor harboring N
    Li R; Yan L; Sun X; Zheng W
    Bioorg Med Chem; 2020 Apr; 28(7):115356. PubMed ID: 32067892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of SIRT2 induces cell death and a decrease in the intracellular ATP level of PC12 cells.
    Nie H; Chen H; Han J; Hong Y; Ma Y; Xia W; Ying W
    Int J Physiol Pathophysiol Pharmacol; 2011; 3(1):65-70. PubMed ID: 21479103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.